.@BCMCancerCenter at Baylor St. Luke’s is becoming the first hospital in the southern U.S. to use both @MagseedSurgery and @Magtrace technology, allowing us to remove tumors in one piece while preserving more tissue, improving patient outcomes. https://t.co/XwTuoVd8Ag
I'm incredibly proud of the amazing work my partner-in-crime, Stacey Carter, has been involved in. She is finding new ways to bring #technology into the world of #medicine, using these innovations to get better results than historically seen. https://t.co/gDMBtVrUIH
New research: "Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial" #BreastCancer#Oncology#ClinicalTrial @StLukesHealthMD https://t.co/G8JuOwaJ8F
The countdown is on! #Oncology teams at the Dan L Duncan Comprehensive Cancer Center will soon be making a move over to the new O'Quinn Medical Tower, where we will be able to collaborate and innovate even more for our patients. #BreastCancer#OncTwitter
Scroll through the images to see the correlation of Perimeter OCT images to histology. It’s clear to see that the OCT images show cellular-level detail surgeons have never seen before, and it happens all in real time right in the OR.
Learn more: https://t.co/2sQMVsJx1g #MedTech
What kind of features are TNBC tumors with high sTILs more likely to have? New research answers just that: "BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer." https://t.co/y7JbZjX6DB
Performing mastectomies and breast reconstruction simultaneously means less anesthesia and quicker recovery for patients. #BreastCancer surgeons and plastic surgeons working together lead to a simpler process that is easier on the patient overall. https://t.co/T0zfNgZtgZ
Often gone unnoticed by the patient, low-risk DCIS #BreastCancer cells are only caught on mammograms. Some colleagues and I asked if these abnormalities are worth removing. https://t.co/eWvksqLXB4
This day (and every day, in my opinion) should be celebrated by those I have walked through these halls and had challenging conversations with. You all make me better, and I am blown away by the bravery I see day in and day out. #BreastCancer#NationalCancerSurvivorsDay
New finding from researchers that the HER2 suppresses the NR2F1 gene, allowing pre-cancerous cells to move to other organs of the body where they can become cancerous. #BreastCancer#BreastCancerResearch
Research is meant to help, whether it directly affects a patient or not. Share your work with others. Congratulations to researchers for developing a computational approach that enables spatial mapping of single-cell data within tissues. https://t.co/5ZUdrqOwpH
Receiving a breast cancer diagnosis comes with many questions. One of those questions is what food people should eat and avoid while having breast cancer treatment, and how their diet may change.
https://t.co/ifFfN6cwX4
New research, "Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer." #CancerResearchMonth#BreastCancer https://t.co/bFA0D02tIj
New research, "A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer." #CancerResearchMonth#BreastCancer https://t.co/RkrEykykyw
It's #NationalCancerResearchMonth, and I want to show an appreciation for every oncologist, researcher, and research assistant I have had the pleasure of working with. The team at @BCMCancerCenter is incredibly talented and brilliant.
New research to better understand why some women diagnosed with #DCIS may not have benefitted from treatment: "'Is it cancer or not?' A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.
https://t.co/v1fBmrZDeF